The stock of vaccine manufacturer Novavax has fallen in 2022. The company's COVID-19 protein-based vaccine, Nuvaxovid, has gone on sale in Europe and is...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok